Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.
INTRODUCTION: Cigarette smoking remains the leading cause of preventable death worldwide. However, the efficacy of available first-line therapies remains low, particularly in primary care practice where most smokers seek and receive treatment. These observations reinforce the notion that 'one s...
Main Authors: | David, S, Johnstone, E, Churchman, M, Aveyard, P, Murphy, M, Munafò, MR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
by: Uhl, G, et al.
Published: (2010) -
Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.
by: David, S, et al.
Published: (2008) -
Erratum: Genome-wide association for smoking cessation success: Participants in the Patch in Practice trial of nicotine replacement (Pharmacogenomics (2010) 11:3 (357-367))
by: Uhl, G, et al.
Published: (2010) -
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
by: David, S, et al.
Published: (2008) -
Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial.
by: Lindson-Hawley, N, et al.
Published: (2014)